Simplex Trading
TXG icon

Simplex Trading’s 10x Genomics TXG Stock Holding History

Simplex Trading’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.12K Sell
100
-31,800
-100% -$636K ﹤0.01% 8353
2025
Q4 		$520K Sell
31,900
-34,600
-52% -$523K ﹤0.01% 3268
2025
Q3 		$777K Buy
66,500
+100
+0.2% +$1.3K ﹤0.01% 3311
2025
Q2 		$768K Buy
66,400
+62,600
+1,647% +$571K ﹤0.01% 3063
2025
Q1 		$33K Sell
3,800
-2,500
-40% -$31.5K ﹤0.01% 6174
2024
Q4 		$90K Buy
6,300
+2,300
+58% +$36.3K ﹤0.01% 5281
2024
Q3 		$90K Buy
4,000
+900
+29% +$18.6K ﹤0.01% 5345
2024
Q2 		$60K Sell
3,100
-5,800
-65% -$152K ﹤0.01% 5897
2024
Q1 		$334K Sell
8,900
-6,500
-42% -$286K ﹤0.01% 4271
2023
Q4 		$861K Sell
15,400
-4,800
-24% -$209K ﹤0.01% 3147
2023
Q3 		$833K Sell
20,200
-8,900
-31% -$463K ﹤0.01% 2864
2023
Q2 		$1.62M Buy
29,100
+18,100
+165% +$980K ﹤0.01% 2146
2023
Q1 		$613K Buy
11,000
+10,700
+3,567% +$500K ﹤0.01% 3064
2022
Q4 		$10K Sell
300
-18,100
-98% -$592K ﹤0.01% 7581
2022
Q3 		$524K Sell
18,400
-6,000
-25% -$229K ﹤0.01% 3413
2022
Q2 		$1.1M Buy
24,400
+15,600
+177% +$809K ﹤0.01% 2507
2022
Q1 		$669K Buy
+8,800
New +$770K ﹤0.01% 3445
2021
Q4 		– Sell
-700
Closed -$132K – 11469
2021
Q3 		$132K Hold
700
– – ﹤0.01% 6232
2021
Q2 		$137K Buy
700
+696
+17,400% +$126K ﹤0.01% 6274
2021
Q1 		$72K Sell
4
-93
-96% -$16.1K ﹤0.01% 6175
2020
Q4 		$1.37M Buy
97
+48
+98% +$6.96K ﹤0.01% 2164
2020
Q3 		$610K Buy
49
+34
+227% +$3.57K ﹤0.01% 2771
2020
Q2 		$133K Sell
15
-6
-29% -$467 ﹤0.01% 4485
2020
Q1 		$130K Sell
21
-22
-51% -$1.72K ﹤0.01% 4091
2019
Q4 		$327K Buy
+43
New +$2.58K ﹤0.01% 3184

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Simplex Trading's TXG Position: Q1 2026 in Review

Simplex Trading sold out of 10x Genomics (TXG) in Q1 2026, closing a stake of 15,986 shares — an estimated $320K sold.

Simplex Trading first reported a position in TXG in Q4 2019 and held it in 12 quarters. The position peaked at $794K in Q4 2023. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Simplex Trading reported no remaining 10x Genomics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 15,986 10x Genomics shares in Q1 2026, an estimated $320K.
  • Simplex Trading first reported a position in 10x Genomics in Q4 2019 and held it in 12 quarters.
  • Simplex Trading's 10x Genomics position peaked at $794K in Q4 2023.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.